![Maria Ekblad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Ekblad
Direttore Tecnico/Scientifico/R&S presso
FOLLICUM AB (PUBL)
Profilo
Maria Ekblad currently works at Follicum AB, as Director-Research & Development from 2016 and Iconovo AB, as Head-Generics Development from 2023.
Ms. Ekblad also formerly worked at Aptahem AB, as Chief Operating Officer from 2022 to 2023.
Ms. Ekblad received her graduate degree from the University of Lund.
Posizioni attive di Maria Ekblad
| Società | Posizione | Inizio |
|---|---|---|
| FOLLICUM AB (PUBL) | Direttore Tecnico/Scientifico/R&S | 01/01/2016 |
| ICONOVO AB | Corporate Officer/Principal | 01/01/2023 |
Precedenti posizioni note di Maria Ekblad
| Società | Posizione | Fine |
|---|---|---|
| APTAHEM AB | Direttore operativo | 01/10/2023 |
Formazione di Maria Ekblad
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
34
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Follicum AB
 Follicum AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for the treatment of hair-loss | Health Technology |
Iconovo AB
 Iconovo AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that manufactures and wholesales powder-based inhalation drugs and devices | Health Technology |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Engages in the pharmaceutical businesses, which research and develops medicines for treating and preventing diseases caused by blockage of blood vessels, such as deep vein thrombosis, stroke and heart failure | Health Technology |
